SCHEMBL22929925

SCHEMBL22929925

c1cc(-c2ccc3c(c2)-c2ccccc2-c2ccccc2-c2cc(-n4c5ccccc5c5cncnc54)ccc2-3)cc(-c2ccc3c(c2)-c2ccccc2-c2ccccc2-c2ncccc2-3)c1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.33
CYP1A2 P05177 6/20 0.32
CYP2C19 P33261 6/20 0.32
USP2 O75604 5/20 0.32
CYP3A4 P08684 5/20 0.32
TSHR P16473 3/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HBB P68871 1/20 0.32
CYP2C9 P11712 5/20 0.32
MAPK1 P28482 2/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MKNK2 Q9HBH9 1/20 0.31
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22929949 0.90
SCHEMBL22929924 0.90 ALDH1A1 (0.34) CYP2C19TSHRMEN1KMT2AALDH1A1
SCHEMBL22929989 0.85
SCHEMBL22929955 0.84 ATM (0.35) PDE10AMEN1KMT2AHSD17B10ALDH1A1
SCHEMBL22929928 0.83 ALDH1A1 (0.30) CYP2C19TSHRALDH1A1
SCHEMBL22930027 0.79 KDM4E (0.41) MEN1KMT2AHIF1AHSD17B10ALDH1A1
SCHEMBL18252308 0.79 ALDH1A1 (0.40) PDE10ACYP2C19TSHRMEN1KMT2A
SCHEMBL22929959 0.79 PIM1 (0.32) PDE10A
SCHEMBL22929960 0.78 TGFBR1 (0.35) CYP1A2CYP2C19KMT2ACYP2C9
SCHEMBL22929893 0.77 PTPRC (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10910577-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910577-B2 Organic electroluminescent materials and devices CACNA2D2, ORC3, ANO2 PDE10A 704/4885CYP1A2 3460/4885CYP2C19 3006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.